FSGS Clinical Trial

NCT03493685 | Phase 3 | Interventional

Sponsored by

Retrophin, Inc.

Have you or a loved one been diagnosed with focal segmental glomerulosclerosis? You may be eligible to participate in a focal segmental glomerulosclerosis clinical trial.

  • Currently Recruiting
  • Male & Female Participants
  • 8-75 years old

*This study is looking to recruit 300 participants

To determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker in patients with primary focal segmental glomerulosclerosis (FSGS).

Study Locations

To get started, select a research facility. All study-related procedures will take place at the facility you select.

Royal Adelaide Hospital                                                                  Recruiting – Port Road, Adelaide, South Australia, AUS 5000

Washington Nephrology Associates                                                                Recruiting – 4141 Duke Street, Alexandria, VA, USA 22304


We're not around right now. But you can send us an email and we'll get back to you, asap.


©2017 My City Med. All Rights Reserved.


Log in with your credentials


Forgot your details?


Create Account